Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents

Although yeast bloodstream infections (BSIs) are increasingly being reported in patients with hematological malignancies undergoing antifungal therapy, clinical information regarding breakthrough infections is scarce. The aim of this study was to determine the risk factors for and clinical outcomes...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Med Mycol
Prif Awduron: Kim, Si-Hyun, Choi, Jae-Ki, Cho, Sung-Yeon, Lee, Hyo-Jin, Park, Sun Hee, Choi, Su-Mi, Lee, Dong-Gun, Choi, Jung-Hyun, Yoo, Jin-Hong, Lee, Jong-Wook
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896439/
https://ncbi.nlm.nih.gov/pubmed/28525644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/mmy/myx038
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg